These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1096900)

  • 1. [Clinical-pharmacological and pharmacokinetic studies with naproxen].
    Boost G
    Arzneimittelforschung; 1975 Feb; 25(2A):281-7. PubMed ID: 1096900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
    Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of repeated dosing with aspirin on plasma levels of naproxen (D-2-(6'-methoxy-2'-naphthyl)-propionic acid) in rats.
    Chaplin MD; Chu NI; Rice BG; Hama KM
    Proc West Pharmacol Soc; 1975; 18():62-6. PubMed ID: 1182041
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naproxen metabolism in man.
    Segre EJ
    J Clin Pharmacol; 1975 Apr; 15(4 Pt. 2):316-23. PubMed ID: 1127135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naproxen plasma levels in volunteers after single-dose administration by oral and rectal routes.
    Desager JP; Vanderbist M; Harvengt C
    J Clin Pharmacol; 1976 Apr; 16(4):189-93. PubMed ID: 1262531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and synovial fluid kinetics, disposition, and urinary excretion of naproxen in horses.
    Soma LR; Uboh CE; Rudy JA; Perkowski SZ
    Am J Vet Res; 1995 Aug; 56(8):1075-80. PubMed ID: 8533980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naproxen sodium (Anaprox): pharmacology, pharmacokinetics and drug interactions.
    Segre EJ
    J Reprod Med; 1980 Oct; 25(4 Suppl):222-5. PubMed ID: 7001021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diflunisal on the human plasma levels and on the urinary excretion of naproxen.
    Dresse A; Gerard MA; Quinaux N; Fischer P; Gerardy J
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):276-84. PubMed ID: 371561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antacid and aspirin on the bioavailability of isofezolac in man.
    Rocher I; Henry JF; Flouvat B
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):464-9. PubMed ID: 6500763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of naproxen in the dog.
    Frey HH; Rieh B
    Am J Vet Res; 1981 Sep; 42(9):1615-7. PubMed ID: 7325471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Mylanta on naproxen bioavailability.
    Weber SS; Bankhurst AD; Mroszczak E; Ding TL
    Ther Drug Monit; 1981; 3(1):75-83. PubMed ID: 7233492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependent pharmacokinetics of naproxen in man.
    Niazi SK; Alam SM; Ahmad SI
    Biopharm Drug Dispos; 1996 May; 17(4):355-61. PubMed ID: 8743406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum protein binding and elimination half-lives of naproxen in patients with hepatocellular or obstructive icterus (author's transl)].
    Held H
    Arzneimittelforschung; 1980; 30(5):843-6. PubMed ID: 7190433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a controlled release preparation of naproxen.
    Strocchi E; Ambrosioni E; Palazzini E; Galli G
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):253-6. PubMed ID: 1889910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
    Schiff M; Hochberg MC; Oldenhof J; Brune K
    Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Double-blind comparison of naproxen against indometacin in osteoarthrosis.
    Clarke AK
    Arzneimittelforschung; 1975 Feb; 25(2A):302-4. PubMed ID: 1096901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of naproxen on protein binding of warfarin in human serum.
    Yacobi A; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):369-72. PubMed ID: 981793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.